| 药品名称 | 活性成分 | 中文名 | 剂型 | ATC编码 | 参照成员国 | 上市许可持有人 | 获批时间 | 市场状态 |
|---|---|---|---|---|---|---|---|---|
| Doxylamine/Pirodixina 20 mg/ 20 mg gastro-resistant tablets | Doxylaminesuccinate20mg,Pyridoxinehydrochloride20mg | 琥珀酸多西拉敏;维生素B6 | Modified-release tablet | R06AA59 | 爱尔兰 | Exeltis Healthcare S.L. | 2023-01-18 | Positive |
| Doxylamine/Pyridoxine Exeltis 10/10mg Gastro-resistant Tablet | Doxylaminesuccinate10mg,PYRIDOXINEHYDROCHLORIDE10mg | 琥珀酸多西拉敏;维生素B6 | Gastro-resistant tablet | R06AA59 | 爱尔兰 | Exeltis Healthcare S.L. | 2021-09-09 | Positive |
| Navalem 10 mg/10 mg modified release capsules, hard | Doxylaminesuccinate10mg,PYRIDOXINEHYDROCHLORIDE10mg | 琥珀酸多西拉敏;维生素B6 | Modified-release capsule, hard | R06AA59 | 西班牙 | Inibsa Ginecología S.A. | 2017-08-16 | Positive |
| Xonvea MR 20 mg/20 mg modified-release tablets | Doxylaminesuccinate20mg,Pyridoxinehydrochloride20mg | 琥珀酸多西拉敏;维生素B6 | Modified-release tablet | R06AA59 | 爱尔兰 | Exeltis Healthcare S.L. | 2023-01-18 | Positive |
| Doxpirexel 20 mg/ 20 mg modified-release tablets | Doxylaminesuccinate20mg,Pyridoxinehydrochloride20mg | 琥珀酸多西拉敏;维生素B6 | Modified-release tablet | R06AA59 | 爱尔兰 | Exeltis Healthcare S.L. | 2023-01-18 | Positive |
